Literature DB >> 16502306

Assessment of structure and function over a 3-year period after gene transfer in RPE65-/- dogs.

Kristina Narfström1, Martin Katz, Ragnheidur Bragadottir, Elizabeth P Rakoczy, Mathias Seeliger.   

Abstract

AIM: To assess retinal structure and function over a 3-year period in a group of five RPE65-/- dogs treated by unilateral rAAV- mediated subretinal gene transfer.
METHODS: Post-operative functional follow-ups were performed using simultaneous, bilateral, full-field ERGs. Structure was evaluated by SLO using FL and ICG angiography and by EM.
RESULTS: Significant improvement of retinal function was observed through ERGs approximately 4 weeks following surgery. Scotopic b-wave amplitudes peaked 3 months after surgery. Then there was a successive reduction, although greater amplitudes than base-line values were observed at all post-operative time points. A-wave amplitudes increased at a later time than b-wave amplitudes and were sustained throughout the follow-up period. The increased cone function was preserved longer than the rod function. Angiography showed structural changes at the site of injection, corroborated by photoreceptor destruction observed ultrastructurally. Immediately adjacent to the subretinal injection area photoreceptor outer segments appeared normal.
CONCLUSION: Despite local structural alterations at the subretinal injection site, subretinal gene transfer in the RPE65 null mutation dog effectively increases retinal function for at least 3 years after surgery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16502306     DOI: 10.1007/s10633-005-3159-0

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  20 in total

Review 1.  The implications of rod-dependent cone survival for basic and clinical research.

Authors:  D Hicks; J Sahel
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-12       Impact factor: 4.799

2.  RPE65 is the isomerohydrolase in the retinoid visual cycle.

Authors:  Gennadiy Moiseyev; Ying Chen; Yusuke Takahashi; Bill X Wu; Jian-Xing Ma
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-22       Impact factor: 11.205

3.  Mutations in RPE65 cause Leber's congenital amaurosis.

Authors:  F Marlhens; C Bareil; J M Griffoin; E Zrenner; P Amalric; C Eliaou; S Y Liu; E Harris; T M Redmond; B Arnaud; M Claustres; C P Hamel
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

4.  Retinal dystrophy of Swedish briard/briard-beagle dogs is due to a 4-bp deletion in RPE65.

Authors:  A Veske; S E Nilsson; K Narfström; A Gal
Journal:  Genomics       Date:  1999-04-01       Impact factor: 5.736

5.  Rapid restoration of visual pigment and function with oral retinoid in a mouse model of childhood blindness.

Authors:  J P Van Hooser; T S Aleman; Y G He; A V Cideciyan; V Kuksa; S J Pittler; E M Stone; S G Jacobson; K Palczewski
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

6.  Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB.

Authors:  P Löser; G S Jennings; M Strauss; V Sandig
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

7.  Slowly progressive changes of the retina and retinal pigment epithelium in Briard dogs with hereditary retinal dystrophy. A morphological study.

Authors:  A Wrigstad; K Narfström; S E Nilsson
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

8.  Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog.

Authors:  Kristina Narfström; Martin L Katz; Ragnheidur Bragadottir; Mathias Seeliger; Ana Boulanger; T Michael Redmond; Lynette Caro; Chooi-May Lai; P Elizabeth Rakoczy
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-04       Impact factor: 4.799

9.  Gene transfer in the RPE65 null mutation dog: relationship between construct volume, visual behavior and electroretinographic (ERG) results.

Authors:  Marnie Ford; Ragnheidur Bragadóttir; P Elizabeth Rakoczy; Kristina Narfström
Journal:  Doc Ophthalmol       Date:  2003-07       Impact factor: 2.379

10.  Recombinant adeno-associated virus type 2-mediated gene delivery into the Rpe65-/- knockout mouse eye results in limited rescue.

Authors:  Chooi-May Lai; Meaghan Jt Yu; Meliha Brankov; Nigel L Barnett; Xiaohuai Zhou; T Michael Redmond; Kristina Narfstrom; P Elizabeth Rakoczy
Journal:  Genet Vaccines Ther       Date:  2004-04-27
View more
  24 in total

1.  Histopathology and functional correlations in a patient with a mutation in RPE65, the gene for retinol isomerase.

Authors:  Vera L Bonilha; Mary E Rayborn; Yong Li; Gregory H Grossman; Eliot L Berson; Joe G Hollyfield
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-28       Impact factor: 4.799

Review 2.  RPE65: role in the visual cycle, human retinal disease, and gene therapy.

Authors:  Xue Cai; Shannon M Conley; Muna I Naash
Journal:  Ophthalmic Genet       Date:  2009-06       Impact factor: 1.803

Review 3.  Statement of the DOG, the RG, and the BVA on the therapeutic use of voretigene neparvovec (Luxturna™) in ophthalmology. English version : January 2019.

Authors: 
Journal:  Ophthalmologe       Date:  2020-01       Impact factor: 1.059

Review 4.  A comprehensive review of retinal gene therapy.

Authors:  Shannon E Boye; Sanford L Boye; Alfred S Lewin; William W Hauswirth
Journal:  Mol Ther       Date:  2013-01-29       Impact factor: 11.454

Review 5.  Gene therapy approaches for the treatment of retinal disorders.

Authors:  Lolita Petit; Claudio Punzo
Journal:  Discov Med       Date:  2016-10       Impact factor: 2.970

Review 6.  Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy.

Authors:  Artur V Cideciyan
Journal:  Prog Retin Eye Res       Date:  2010-04-24       Impact factor: 21.198

7.  Mutation discovered in a feline model of human congenital retinal blinding disease.

Authors:  Marilyn Menotti-Raymond; Koren Holland Deckman; Victor David; Jaimie Myrkalo; Stephen J O'Brien; Kristina Narfström
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-06       Impact factor: 4.799

Review 8.  The use of canine models of inherited retinal degeneration to test novel therapeutic approaches.

Authors:  William A Beltran
Journal:  Vet Ophthalmol       Date:  2009 May-Jun       Impact factor: 1.644

Review 9.  Contemporary Animal Models For Human Gene Therapy Applications.

Authors:  Chitra Gopinath; Trupti Job Nathar; Arkasubhra Ghosh; Dennis Durand Hickstein; Everette Jacob Remington Nelson
Journal:  Curr Gene Ther       Date:  2015       Impact factor: 4.391

10.  Topographical characterization of cone photoreceptors and the area centralis of the canine retina.

Authors:  Freya M Mowat; Simon M Petersen-Jones; Helen Williamson; David L Williams; Philip J Luthert; Robin R Ali; James W Bainbridge
Journal:  Mol Vis       Date:  2008-12-29       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.